BRNS:NASDAQ
Barinthus Biotherapeutics PLC - ADR
$0.68
arrow_upward
+0.12%(+0.00080) 1D
May 29, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BRNS...
Open
$0.66
High
$0.68
Low
$0.66
Mkt. cap
27.94M
Avg. vol.
21.09K
Volume
2.34K
52-wk high
$2.92
52-wk low
$0.51
EPS
-$1.29
Beta
-0.43
Shares outstanding
40.85M
No. of employees
14
Open
$0.66
High
$0.68
Low
$0.66
Mkt. cap
27.94M
Avg. vol.
21.09K
Volume
2.34K
52-wk high
$2.92
52-wk low
$0.51
EPS
-$1.29
Beta
-0.43
Shares outstanding
40.85M
No. of employees
14
News stories
From sources across the web
The Legal Advocate
·
2 weeks ago
Barinthus (BRNS) Q1 2026 Earnings: Why the Beat Matters - Diluted EPS Report
Profile
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
About Barinthus Biotherapeutics PLC - ADR
AI content may include mistakes. Learn more